A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors.
Saved in:
| Title: | A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors. |
|---|---|
| Authors: | Golbourn B; John G. Rangos Sr. Research Center, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.; Cell Biology Research Program, The Hospital for Sick Children, Toronto, Ontario, Canada., Ho B; Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Division of Hematology and Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada., Bondoc A; Cell Biology Research Program, The Hospital for Sick Children, Toronto, Ontario, Canada., Luck A; Cell Biology Research Program, The Hospital for Sick Children, Toronto, Ontario, Canada., Fan X; Cell Biology Research Program, The Hospital for Sick Children, Toronto, Ontario, Canada., Richardson E; Cell Biology Research Program, The Hospital for Sick Children, Toronto, Ontario, Canada., Marcellus R; Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Prakesch M; Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Halbert M; John G. Rangos Sr. Research Center, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Agrawal N; John G. Rangos Sr. Research Center, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA., Smith C; Cell Biology Research Program, The Hospital for Sick Children, Toronto, Ontario, Canada., Huang A; Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Division of Hematology and Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.; Department of Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Rutka JT; Cell Biology Research Program, The Hospital for Sick Children, Toronto, Ontario, Canada.; Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Division of Neurosurgery, The Hospital for Sick Children, Toronto, Ontario, Canada. |
| Source: | Neuro-oncology [Neuro Oncol] 2024 Oct 03; Vol. 26 (10), pp. 1895-1911. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38981018 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Golbourn+B%22">Golbourn B</searchLink>; John G. Rangos Sr. Research Center, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.; Cell Biology Research Program, The Hospital for Sick Children, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Ho+B%22">Ho B</searchLink>; Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Division of Hematology and Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Bondoc+A%22">Bondoc A</searchLink>; Cell Biology Research Program, The Hospital for Sick Children, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Luck+A%22">Luck A</searchLink>; Cell Biology Research Program, The Hospital for Sick Children, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Fan+X%22">Fan X</searchLink>; Cell Biology Research Program, The Hospital for Sick Children, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Richardson+E%22">Richardson E</searchLink>; Cell Biology Research Program, The Hospital for Sick Children, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Marcellus+R%22">Marcellus R</searchLink>; Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Prakesch+M%22">Prakesch M</searchLink>; Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Halbert+M%22">Halbert M</searchLink>; John G. Rangos Sr. Research Center, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Agrawal+N%22">Agrawal N</searchLink>; John G. Rangos Sr. Research Center, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Smith+C%22">Smith C</searchLink>; Cell Biology Research Program, The Hospital for Sick Children, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Huang+A%22">Huang A</searchLink>; Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Division of Hematology and Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.; Department of Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Rutka+JT%22">Rutka JT</searchLink>; Cell Biology Research Program, The Hospital for Sick Children, Toronto, Ontario, Canada.; Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Division of Neurosurgery, The Hospital for Sick Children, Toronto, Ontario, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100887420%22">Neuro-oncology</searchLink> [Neuro Oncol] 2024 Oct 03; Vol. 26 (10), pp. 1895-1911. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100887420 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1523-5866 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215228517%22">15228517 </searchLink><i>NLM ISO Abbreviation: </i>Neuro Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38981018 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/neuonc/noae120 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1895 Titles: – TitleFull: A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Golbourn B – PersonEntity: Name: NameFull: Ho B – PersonEntity: Name: NameFull: Bondoc A – PersonEntity: Name: NameFull: Luck A – PersonEntity: Name: NameFull: Fan X – PersonEntity: Name: NameFull: Richardson E – PersonEntity: Name: NameFull: Marcellus R – PersonEntity: Name: NameFull: Prakesch M – PersonEntity: Name: NameFull: Halbert M – PersonEntity: Name: NameFull: Agrawal N – PersonEntity: Name: NameFull: Smith C – PersonEntity: Name: NameFull: Huang A – PersonEntity: Name: NameFull: Rutka JT IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 10 Text: 2024 Oct 03 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1523-5866 Numbering: – Type: volume Value: 26 – Type: issue Value: 10 Titles: – TitleFull: Neuro-oncology Type: main |
| ResultId | 1 |